Possible montelukast-induced angioedema

LAUR Repository

Show simple item record

dc.contributor.author Sabbagh, Racha
dc.contributor.author Sheikh-Taha, Marwan
dc.date.accessioned 2016-06-02T08:23:58Z
dc.date.available 2016-06-02T08:23:58Z
dc.date.copyright 2009 en_US
dc.date.issued 2016-06-02
dc.identifier.issn 1695-0674 en_US
dc.identifier.uri http://hdl.handle.net/10725/3925
dc.description.abstract Purpose. A possible case of montelukast-induced angioedema is reported. Summary. A 46-year-old woman with a history of severe allergies, including food allergies, and angioedema was evaluated at the emergency department (ED) for an acute episode of angioedema. Upon arrival at the ED, the patient had severe jaw tightness, facial numbness, uncontrollable cheek lifting, swollen eyes, and a swollen protruding tongue and was unable to catch her breath. Her dyspnea was apparent, and she was unable to talk and instead used hand and face gestures for affirmative and negative responses. The patient was treated with 0.3 mg epinephrine intramuscularly into the right thigh. After treatment, she had a temperature of 37 °C, a pulse of 90 beats/ min, a blood pressure value of 100/59 mm Hg, a respiratory rate of 16 breaths/min, and 100% oxygen saturation on room air. After stabilization, she reported that her allergies had been adequately controlled with ebastine 10 mg daily, montelukast 10 mg daily, and vitamins (unspecified). The patient reported that since she started montelukast one month prior, she experienced three similar episodes, the first occurring five days after starting the drug. She mentioned being diagnosed and adequately treated these three times in the ED for angioedema. The patient denied any changes in eating habits or in her medications except for starting montelukast. She was observed at the ED for an hour and then discharged after stabilization on hydroxyzine hydrochloride 25 mg orally daily and fexofenadine hydrochloride 180 mg orally daily. Montelukast was discontinued. Conclusion. A patient developed angioedema four times during one month of treatment with montelukast. en_US
dc.language.iso en en_US
dc.title Possible montelukast-induced angioedema en_US
dc.type Article en_US
dc.description.version Published en_US
dc.author.school SOP en_US
dc.author.idnumber 199410150 en_US
dc.author.department Pharmacy Practice Department en_US
dc.description.embargo N/A en_US
dc.relation.journal American Journal of Health-System Pharmacy en_US
dc.journal.volume 66 en_US
dc.journal.issue 19 en_US
dc.article.pages 1705-1706 en_US
dc.identifier.doi http://dx.doi.org/10.2146/ajhp080408 en_US
dc.identifier.ctation Sabbagh, R., & Sheikh-Taha, M. (2009). Possible montelukast-induced angioedema. American Journal of Health-System Pharmacy, 66(19), 1705-1706. en_US
dc.author.email marwan.taha@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url http://web.b.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=0&sid=c00270ab-a03f-4a2b-9d19-9a976592e3fc%40pdc-v-sessmgr06 en_US
dc.orcid.id https://orcid.org/0000-0002-8037-1201 en_US

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account